Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways

Mostrar otras versiones (1)

A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajpal, Saurabh, Kahwash, Rami, Tong, Matthew S., Paschke, Kelly, Satoskar, Anjali A., Foreman, Beth, Allen, Larry A., Bhave, Nicole M., Gluckman, Ty J., Fuster, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2022
Materias:
The Present and Future
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961313/
https://www.ncbi.nlm.nih.gov/pubmed/35364210
http://dx.doi.org/10.1016/j.jacc.2022.03.346
Descripción
Sumario:A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.

Ejemplares similares